Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 30 March

Grady Wulff
March 30, 2023

Morning Bell 29 March

Grady Wulff
March 29, 2023

Morning Bell 28 March

Sophia Mavridis
March 28, 2023

Morning Bell 27 March

Grady Wulff
March 27, 2023

Weekly Wrap 24 March

Sophia Mavridis
March 24, 2023

Morning Bell 24 March

Sophia Mavridis
March 24, 2023

Morning Bell 23 March

Sophia Mavridis
March 23, 2023

Morning Bell 22 March

Grady Wulff
March 22, 2023

Morning Bell 21 March

Grady Wulff
March 21, 2023

Morning Bell 20 March

Grady Wulff
March 20, 2023

Weekly Wrap 17 March

Grady Wulff
March 17, 2023

Morning Bell 17 March

Sophia Mavridis
March 17, 2023